1Department of Pediatric Neurosurgery, Dana Dwek Children Hospital, Tel Aviv Medical Center, Tel Aviv; and.
2Tel Aviv University, Tel Aviv, Israel.
J Neurosurg Pediatr. 2022 Dec 16;31(3):238-244. doi: 10.3171/2022.11.PEDS22406. Print 2023 Mar 1.
Ventriculoperitoneal shunt placement is the most common treatment for hydrocephalus. However, most patients will require multiple shunt revisions over time. In cases of peritoneal shunt failure, the pleura and heart are alternative distal sites. Sinus shunts have been described but are not commonly used. The potential vascular complications, as well as inexperience with these shunts, make these tools less attractive. The goal of this study was to share the authors' experience with ventriculosinus shunts (VSSs) in selected patients.
Between December 2018 and February 2022, a total of 7 patients (1 adult, 6 children) underwent 11 surgeries for the placement of a VSS at the authors' institution. Data regarding complications and shunt function were retrospectively collected and assessed, and a review of the literature was conducted.
The mean (± standard deviation) age at surgery was 11.9 ± 12.8 years (range 1.3-38.2 years). All patients had had previous shunt systems that failed and systemic conditions that made other distal sites less desirable. In all cases, a low-pressure differential valve was installed. Over a mean follow-up of 18 ± 9.8 months (range 9-39 months), 4 of the 7 patients underwent additional shunt revisions, 2 of whom had shunts placed at other sites. One patient had symptomatic partial sinus thrombosis, managed conservatively. During follow-up, 5 patients showed improvement in their symptoms of high intracranial pressure using the VSS. There were no severe complications of air embolism, bleeding, or infection.
VSSs may have a role to play in selected patients in whom more commonly used distal shunt locations have failed. Significant complications with these shunts are rare. Additional experience is needed to better understand the ideal catheter and placement locations.
脑室-腹腔分流术是脑积水最常见的治疗方法。然而,大多数患者随着时间的推移需要多次分流器修订。在腹膜分流器失败的情况下,胸膜和心脏是替代的远端部位。已经描述了窦分流器,但不常用。这些分流器潜在的血管并发症以及使用经验不足,使得这些工具的吸引力降低。本研究的目的是分享作者在选定患者中使用脑室-窦分流器(VSS)的经验。
在 2018 年 12 月至 2022 年 2 月期间,作者所在机构共对 7 名患者(1 名成人,6 名儿童)进行了 11 次 VSS 植入手术。回顾性收集并评估了并发症和分流器功能的数据,并进行了文献复习。
手术时的平均(±标准差)年龄为 11.9 ± 12.8 岁(范围 1.3-38.2 岁)。所有患者之前的分流系统都失败了,并且存在使其他远端部位不太理想的全身状况。在所有情况下,都安装了低压差式阀。在平均随访 18 ± 9.8 个月(范围 9-39 个月)后,7 名患者中有 4 名需要进行额外的分流器修订,其中 2 名患者在其他部位放置了分流器。1 名患者出现症状性部分窦血栓形成,采用保守治疗。在随访期间,5 名患者使用 VSS 改善了其颅内压升高的症状。没有出现严重的空气栓塞、出血或感染并发症。
VSS 可能在更常用的远端分流部位失败的选定患者中发挥作用。这些分流器的严重并发症很少见。需要更多的经验来更好地了解理想的导管和放置位置。